Tamim Niazi, MD
Jewish General Hospital · Jewish General Hospital, McGill University · Sir Mortimer B. Davis - Jewish General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tamim Niazi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:32 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04070209 · Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)Sir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Metastatic Prostate Cancer, Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT03763851 · Cannabis Oil and Radiation Therapy for the Management of PainTetra Bio-Pharma · terminated · Metastatic Prostate Cancer, Lung Cancer, Breast Cancer · principal investigator
- Ph2/Ph3NCT02685397 · Management of Castration-Resistant Prostate Cancer with OligometastasesSir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Castration-resistant Prostate Cancer Patients with Oligometastases · principal investigator
- Ph3NCT02303327 · Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer PatientsSir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Prostate Cancer · principal investigator
- Ph3NCT02220829 · Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation TherapySir Mortimer B. Davis - Jewish General Hospital · completed · Urinary Problems, Prostate Cancer · principal investigator
- Ph3NCT01444820 · Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the ProstateSir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Prostate Cancer · principal investigator
- N/ANCT01350180 · Assessing DNA Changes in High Risk Prostate Cancer to Determine PrognosisDr. Tamim Niazi · withdrawn · Prostate Cancer · principal investigator
- Ph2NCT01255891 · Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma ProstateDr. Tamim Niazi · completed · Adenocarcinoma of the Prostate · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.